These .CEL files correspond to GSE36149
at the Gene Expression Omnibus database:
 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36149
(GEO Accession: GSE36149)

Title: Gene expression data from 
       obatoclax-treated SEM-K2 and 
       RS4:11 cell lines 

Notes: Obatoclax mesylate is an experimental drug
       for treating acute lymphoblastic leukemia
       in infants.  It is owned by GeminX Pharmaceuticals.
       This study was conducted to better understand 
       exactly what the drug does to kill leukemia cells.

Overview:
Tissue samples were taken from two human leukemia cell lines
(Line; R = RS4:11, S = SEM-K2), originally cultured from
infant leukemia blood.  Three treatments were compared
(Trt; C = control, L = low-dose obatoclax, H = high-dose
obatoclax).  Two replicates (Rep) were run at each cell line
/ treatment combination, for a total sample size of 12.

         Sample   Trt  Line  Rep  CELfile
        GSM881823  C    R     1   CR1.CEL
        GSM881824  L    R     1   LR1.CEL
        GSM881825  H    R     1   HR1.CEL
        GSM881826  C    S     1   CS1.CEL
        GSM881827  L    S     1   LS1.CEL
        GSM881828  H    S     1   HS1.CEL
        GSM881829  C    R     2   CR2.CEL
        GSM881830  L    R     2   LR2.CEL
        GSM881831  H    R     2   HR2.CEL
        GSM881832  C    S     2   CS2.CEL
        GSM881833  L    S     2   LS2.CEL
        GSM881834  H    S     2   HS2.CEL
